Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin vs Amoxicillin and Metronidazole for Aggressive Periodontitis
NCT02839421Phase 4Unknown
- Sponsor
- Facultad Nacional de Salud Pública
- Start
- Dec 2015
- Primary completion
- May 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of moxifloxacin in Aggressive Periodontitis (AP), sponsored by Facultad Nacional de Salud Pública. Primary endpoint: Clinical Attachment Level at 6 months. Status: unknown.
02
Drugs
moxifloxacin
03
Conditions
Aggressive Periodontitis (AP)
Beyond the preview
Go deeper on NCT02839421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02839421.